← Back to Conditions

Progressive familial intrahepatic cholestasis type 2

disorder
SNOMED 1155841005CUI C3489789

Overview

Progressive familial intrahepatic cholestasis type 2 is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Clinical Trials

1
Total Trials
0
Recruiting
1
With Results

Recent Trials

Impact of Metformin and Polysorbate 80 on Drug Absorption and Disposition

NCT04640571Phase 4Completed18 enrolled
View all 1 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Cirrhosis
HP:0001394
Conjugated hyperbilirubinemia
HP:0002908
Decreased body height
HP:0004322
Diarrhea
HP:0002014
Elevated alkaline phosphatase
HP:0003155
Enlarged liver
HP:0002240
Fat malabsorption
HP:0002630
Increased incidence of hepatocellular carcinoma
HP:0001402
Intermittent yellowing of skin
HP:0001046
Intrahepatic cholestasis
HP:0001406
Large spleen
HP:0001744
Poor weight gain
HP:0001508
Skin itching
HP:0000989

Related Conditions

Progressive intrahepatic cholestasis(parent)
Neonatal metabolic disorder(parent)
Cholestasis in newborn(parent)

Quick Facts

SNOMED CT
1155841005
UMLS CUI
C3489789
Fully Specified Name
Progressive familial intrahepatic cholestasis type 2 (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
13
Clinical Trials
1
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.